The African Union (AU) has dropped plans to secure coronavirus vaccines from the Serum Institute of India because of supply concerns and is instead exploring options with the US drugmaker, Johnson & Johnson. The head of Africa’s Centres for Disease Control, John Nkengasong, said reliable supplies of vaccines were vital – and that Indian restrictions on exports had complicated things for Africa. He added that the AU’s decision had nothing to do with the possible link to blood clots in rare cases involving the Oxford-AstraZeneca vaccine which will still be supplied to Africa through the UN’s Covax scheme. India’s Serum Institute is licensed to make global supplies of AstraZeneca but Delhi has commandeered stocks to deal with surging infections. Mr Nkengasong said the AU had already signed a deal for up to 400 million single dose jabs from Johnson & Johnson.
SOURCE: BBC
More Stories
Abby Ajayi’s ‘Riches’ Packs in the Drama as Well as the Glitz
“Black Panther: Wakanda Forever” Gets Rave Reviews from African Moviegoers
What to Eat and Drink in South Africa
‘Nanny’ Review: Filmmaker Employs African Folklore in a Haunting Black Horror Film
Finding New Meaning in Timeless Music
Unesco Adds Tunisia’s Harissa and Morocco’s Rai to its List of Intangible Cultural Heritage
At the Edge of the Sahara, a New Model for Refined Regenerative Tourism is being Trailblazed
Victoria Falls Safari Spa has Officially Opened in Zimbabwe
Kigali Held the 8th Edition of the Mashariki African Film Festival this Week
Underrated Small Towns and Villages in South Africa
Lebo M on 25 Years of The Lion King on Broadway
Mountain House Makes the Most of Its Spectacular Site